| 1. |
2023
Garcia-Marcos L,Chiang C-Y,Asher MI,Marks GB,El Sony A,Masekela R, Bissell K, Ellwood E, Ellwood P, Pearce N, et al.
Asthma management and control in children, adolescents and adults: Global Asthma Network (GAN) phase I cross-sectional study
. Lancet Global Health
.2023
;(11):e218-28
|
|
| 2. |
2023
Chiang C-Y,Chen C-H,Feng J-Y,Chiang Y-J,Huang W-C,Lin Y-J, et al.
Prevention and management of tuberculosis in solid organ transplantation: a consensus statement of the Transplantation Society of Taiwan
. J Formos Med Assoc
.2023
|
|
| 3. |
2023
Langan SM,Mulick AR,Rutter CE,Silverwood RJ,Asher MI,García-Marcos L, Ellwood E, Bissell K, Chiang C-Y, et al.
Trends in eczema prevalence in children and adolescents: A Global Asthma Network Phase One Study
. Clinical and Experimental Allergy
.2023
|
|
| 4. |
2023
Incremental yield of serial sputum examinations in the diagnosis of pulmonary tuberculosis in Taiwan: findings of a pragmatic trial.
. J Microbiol Immunol
.2023
|
|
| 5. |
2022
Hughes G,Bern H,Chiang C-Y,Goodall RL,Nunn AJ,Rusen I.D, Meredith S.
ECG monitoring in STREAM Stage 1: Can we identify those at increased risk of QT prolongation?
. Int J Tuberc Lung Dis
.2022
;(66):1065-1070
|
|
| 6. |
2022
Garcia-Marcos L,Asher MI,Pearce N,Ellwood E,Bissell K,Chiang C-Y, El Sony A, Ellwood P, et al.
The burden of asthma, hay fever and eczema in children in 25 countries : GAN Phase I
. Eur Respir J
.2022
;(60):1-12
|
|
| 7. |
2022
Kokebu DM,Ahmed S,Moodliar R,Chiang C-Y,Torrea G,Van Deun A, Goodall RL, Rusen ID, Meredith SK, Nunn AJ.
Failure or relapse predictors for the STREAM Stage 1 short regimen for RR-TB.
. Int J Tuberc Lung Dis
.2022
;(26):753-759
|
|
| 8. |
2022
Hughes G,Bern H,Chiang C-Y,Goodall RL,Nunn AJ,Rusen I.D, Meredith S.
QT prolongation in the STREAM Stage 1 trial
. Int J Tuberc Lung Dis
.2022
;(26):334-340
|
|
| 9. |
2022
Stolbrink M,Chinouya MJ,Jayasooria S,Nightingale R,Evans-Hil L,Allan K, Allen H, Balen J, Beacon T, Bissell K, Chakaya J, Chiang C-Y, Cohen M, Devereux G, El Sony A, Halpin DMG, Hurst J, Kiprop C, … Marks GB, Mortimer K.
Improving access to affordable quality-assured inhaled medicines in low- and middle-income countries
. Int J Tuberc Lung Dis
.2022
;(26):1023-1032
|
|
| 10. |
2022
Chiang C-Y,Ellwood P,Ellwood E,García-Marcos L,Masekela R,Asher I, Badellino H, Sanz A B, Douros K, El Sony A, Diaz C G, Rodríguez M A, Moreno-Salvador A, Pérez-Martini L F, Filho Nelson R, Shpakou A, Sulaimanov S, Tavakol M, Valverde-Molina J, Yousef A A, Pearce N, The GAN COVID Study Group.
Infection with SARS-CoV-2 among children with asthma: evidence from Global Asthma Network
. Pediatr Allergy Immunol
.2022
;(33):1-9
|
|
| 11. |
2022
Strachan DP,Rutter CE,Asher MI ,Bissell K ,Chiang C-Y,El Sony A, Ellwood E, Ellwood P, García-Marcos L, Marks G B, Morales E, Mortimer K, Pearce N, Pérez-Fernández V, Robertson S, Silverwood R J, the Global Asthma Network Phase I Study Group.
Worldwide time trends in prevalence of symptoms of rhinoconjunctivitis in children: Global Asthma Network Phase I.
. Pediatr Allergy Immunol
.2022
;(33):1-12
|
|
| 12. |
2022
Chiang C-Y,Chang J-H,Chuang H-C,Fan C-K,Hou T-Y,Lin C-L, Lee Y-L.
Schisandrin B promotes Foxp3+ regulatory T cell expansion by activating heme oxygenase-1 in dendritic cells and exhibits immunomodulatory effects in Th2-mediated allergic asthma.
. Eur J Pharmacology
.2022
;(918):1-12
|
|
| 13. |
2022
Huang W-C,Lin C-B,Chien S-T,Wang J-Y,Lin C-J,Feng J-Y, Lee C-H, Shu C-C, Yu M-C, Lee J-J, Chiang C-Y.
Performance of nucleic acid amplification tests in patients with presumptive pulmonary tuberculosis: a multi-centre, cross-sectional study in Taiwan
. Infect Dis Ther
.2022
|
|
| 14. |
2022
Lazarchik A,Nyaruhirira A,Chiang C-Y,Wares F,Horsburgh C,Lazarchik A,Nyaruhirira A,Chiang Chen-Yuan,Wares F,Horsburgh C.
Global availability of susceptibility testing for second-line antituberculosis agents
. International Journal of Tuberculosis and Lung Disease
.2022
;(26):524-528
|
|
| 15. |
2022
Chiang C-Y,Lin H-H,Fu H.
Assessment of TB patient cost – what about the mitigation strategy?
. INT J TUBERC LUNG DIS
.2022
;(26):1-4
|
|
| 16. |
2022
Feng J-Y,Lin C-J,Wang J-Y,Chien S-T,Lin C-B ,Huang W-C, Lee C-H, Shu C-C, Yu M-C, Lee J-J, Chiang C-Y.
Would nucleic acid amplification test reduce delayed diagnosis and misdiagnosis of pulmonary tuberculosis?
. Scientific Report
.2022
|
|
| 17. |
2022
Mortimer K,Lesosky M,García-Marcos L,Asher MI,Pearce N,Ellwood E, Bissell K, El Sony A, Ellwood P, Marks GB, Martínez-Torres A, Morales E, Perez-Fernandez V, Robertson S, Rutter C.E., Silverwood R.J., Strachan D.P., Chiang C-Y .
The burden of asthma, hay fever and eczema in adults in 17 countries: GAN Phase I study
. Eur Respir J
.2022
;(60):1-12
|
|
| 18. |
2022
Chiang C-Y,Bissell K,Macé C,Perrin C,Marks G,Mortimer K, El Sony A, Aït-Khaled N, Enarson DA, Billo N.
The Asthma Drug Facility and the future management of asthma
. Int J Tuberc Lung Dis
.2022
;(26):388-391
|
|
| 19. |
2022
Chiang C-Y,El Sony A,Beyers N,Fanning A,Marks GB,Rieder HL, Billo NE.
Donald A Enarson
. INT J TUBERC LUNG DIS
.2022
;(26):803-805
|
|
| 20. |
2022
Goodall RL,Meredith SK,Nunn AJ,Bayissa A,Bhatnagar AK,Bronson G, Chiang C-Y, Conradie F, et al.
Evaluation of two short standardised regimens for the treatment of rifampicin-resistant tuberculosis (STREAM stage 2): an open-label, multicentre, randomised, non-inferiority trial
. Lancet
.2022
|
|
| 21. |
2021
Meghji J,Mortimer K,Agusti A,Allwood BW,Asher I,Bateman ED, Bissell K, Bolton CE, Bush A, Celli B, Chiang C-Y, Cruz AA, Dinh-Xuan A, et al.
Improving lung health in low-income and middle-income countries: from challenges to solutions
. Lancet
.2021
;(397):928-940
|
|
| 22. |
2021
Asher MI,Rutter CE,Bissell K,Chiang C-Y,El Sony A,Ellwood E, Ellwood P, García-Marcos L, Marks G B, Morales E, Mortimer K, Pérez-Fernández V, Robertson S, Silverwood R J, Strachan D P, Pearce N, the Global Asthma Network Phase I Study Group.
Is the worldwide burden of asthma symptoms in school children changing? Global Asthma Network Phase I: repeated cross-sectional studies.
. The Lancet
.2021
;(398):1569-1580
|
|
| 23. |
2020
Trebucq A,Decroo T,Van Deun A,Piubello A,Chiang CY,Koura KG, Schwoebel V.
Short-Course Regimen for Multidrug-Resistant Tuberculosis: A Decade of Evidence
. Journal of Clinical Medicine
.2020
;(9):1-12
|
|
| 24. |
2020
Chiang C-Y,El Sony A.
Tackling the threat of COVID-19 in Africa: an urgent need for practical planning
. Int J Tuberc Lung Dis
.2020
;(24):541-2
|
|
| 25. |
2020
Chiang C-Y,Trebucq A,Piubello A,Rieder HL,Schwoebel V,Van Deun A.
The looming threat of bedaquiline resistance in tuberculosis
. Eur Respir J
.2020
;(55):1-3
|
|
| 26. |
2020
Narmandakh E,Tumenbayar O,Borolzoi T,Erkhembayar B,Boldoo T,Dambaa N, Burneebaatar B, Nyamdawa N, Mitarai S, Jav S, Chiang C-Y.
Genetic Mutations Associated with Isoniazid Resistance in Mycobacterium tuberculosis in Mongolia
. Antimicrobial Agents and Chemotherapy
.2020
;(64):1-7
|
|
| 27. |
2020
Chiang C-Y.
Green Light Committee and recommendations of World Health Organization
. Int J Tuberc Lung Dis
.2020
;(24):873-4
|
|
| 28. |
2020
Chiang C-Y,Bam TS.
The impact of smoking on TB treatment outcomes includes recurrent TB
. Int J Tuberc Lung Dis
.2020
;(24):1224-5
|
|
| 29. |
2020
Phillips PPJ,Van Deun A,Ahmed S,Goodall RL,Meredith SK,Conradie F, Chiang C-Y, Rusen ID, Nunn AJ.
Investigation of the efficacy of the short regimen for rifampicin-resistant TB from the STREAM trial
. BMC Medicine
.2020
|
|
| 30. |
2020
Chiang C-Y,Islam T,,Xu C,Chinnayah T,Garfin AMC,Rahevar K, Raviglione M.
The impact of COVID-19 and the restoration of tuberculosis services in the Western Pacific Region
. Eur Respir J
.2020
;(56):1-3
|
|
| 31. |
2019
Nunn AJ,Phillips PPJ,Meredith SK,Chiang C-Y,Conradie F,Dalai D, et al.
A trial of a shorter regimen for rifampicin-resistant tuberculosis.
. N Engl J Med
.2019
;(380):1201-13
|
|
| 32. |
2019
Asher MI,Bissell K,Chiang C-Y,El Sony A,Ellwood P,García-Marcos L, Marks G, Mortimer K, Pearce N, Strachan DP.
Calling time on asthma deaths in tropical regions—how much longer must people wait for essential medicines?
. Lancet Respiratory Medicine
.2019
|
|
| 33. |
2019
Harries AD,Schwoebel V,Monedero-Recuero I,Aung TK,Chadha S,Chiang C-Y, Conradie F, Dongo J-P, Heldal E, Jensen P, et al.
Challenges and opportunities to prevent tuberculosis in people living with HIV in low-income countries
. Int J Tuberc Lung Dis
.2019
;(23):241-251
|
|
| 34. |
2019
Lee P-H,Chan P-C,Peng Y-T,Chu P-W,Wu M-H,Jou R, Yu M-C, Lin C-J, Huang Y-W, Chien S-T, Lee J-J, Chiang C-Y.
Impact of universal drug susceptibility testing and effective management of multidrug-resistant tuberculosis in Taiwan
. PLoS One
.2019
;(14):1-10
|
|
| 35. |
2019
Bissell K,Ellwood P,Ellwood E,Chiang C-Y,Marks GB,El Sony A, Asher I, Billo N, Perrin C.
Essential Medicines at the National Level: The Global Asthma Network’s Essential Asthma Medicines Survey 2014
. Int J Environ Res Public Health
.2019
;(16):1-15
|
|
| 36. |
2019
Chan PC,Lee PH,Lu MJ,Huang YC,Feng TY,Chen WW, Lee CC, Huang YF, Chiang CY.
Tolerability of rifapentine-based regimens in latent tuberculosis infection treatment in the elderly
. European Respiratory Journal
.2019
;(53)
|
|
| 37. |
2019
Van Deun A,Decroo T,Tahseen S,Trebucq A,Schwoebel V,Ortuno-Gutierrez N, de Jong BC, Rieder HL, Piubello A, Chiang C-Y.
WHO 2018 treatment guidelines for rifampicin-resistant tuberculosis: uncertainty, potential risks and the way forward
. International Journal of Antimicrobial Agents
.2019
|
|
| 38. |
2019
Held K,McAnaw S,Chiang C-Y,Trebucq A,Horsburgh CR.
Progress in global rollout of new multidrug-resistant tuberculosis treatments
. Int J Tuberc Lung Dis
.2019
|
|
| 39. |
2019
Chiang C-Y,Van Deun A,Trebucq A,Piubello A,Schwoebel V,Rieder HL.
Multidrug-resistant tuberculosis
. Lancet
.2019
|
|
| 40. |
2019
Schwoebel V,Chiang C-Y,Trebucq A,Piubello A,Aıt-Khaled N,Koura KG, Heldal E, Van Deun A, Rieder HL.
Outcome definitions for multidrug-resistant tuberculosis treated with shorter treatment regimens
. Int J Tuberc Lung Dis
.2019
;(23):619-624
|
|
| 41. |
2018
Rusen ID,Chiang CY .
Building the evidence base for shortened MDR-TB treatment regimens
. International Journal of Tuberculosis and Lung Disease
.2018
;(22):1-1
|
|
| 42. |
2018
Chiang C-Y,Trébucq A.
Tuberculosis re-treatment after exclusion of rifampicin resistance
. Eur Respir J
.2018
;(51):1-3
|
|
| 43. |
2018
Yu M-C,Chiang, C-Y,Lee J-J,Chien S-T,Lin C-J,Lee S-W, Lin C-B, Yang W-T, Wu Y-H, Huang Y-W.
Treatment outcomes of multidrug-resistant tuberculosis in Taiwan: tackling loss to follow-up
. Clinical Infectious Diseases
.2018
|
|
| 44. |
2018
Chiang C-Y,Trébucq A,Piubello A,Rieder HL,Van Deun A.
Should gatifloxacin be included in the model list of essential medicines?
. Eur Respir J
.2018
;(51):1-2
|
|
| 45. |
2018
Chiang C-Y,Bam T S.
Should tobacco control intervention be implemented into tuberculosis control program?
. Expert Rev Respir Med
.2018
|
|
| 46. |
2018
Lee M-C,Chiang C-Y,Lee C-H,Ho C-M,Chang C-H,Wang J-Y, Chen S-M.
Metformin use is associated with a low risk of tuberculosis among newly diagnosed diabetes mellitus patients with normal renal function: A nationwide cohort study with validated diagnostic criteria.
. PLoS One
.2018
|
|
| 47. |
2017
Van Deun A,Chiang C-Y.
Shortened multidrug-resistant tuberculosis regimens overcome low-level fluoroquinolone resistance
. Eur Respir J
.2017
;(49):1-3
|
|
| 48. |
2017
Xu L,Chen J,Innes AL,Li L,Chiang C-Y.
Prescription practice of anti-tuberculosis drugs in Yunnan, China: a clinical audit.
. PLoS One
.2017
;(12):1-16
|
|
| 49. |
2017
Heldal E,Van Deun A,Chiang C-Y,Rieder HL.
Shorter regimens for multidrug-resistantbtuberculosis should also be applicable in Europe.
. Eur Respir J
.2017
;(49):1-3
|
|
| 50. |
2017
Chiang CY ,Lee CC ,Fan CK ,Huang HM ,Chiang BL,Lee YL.
Osthole treatment ameliorates Th2-mediated allergic asthma and exerts immunomodulatory effects on dendritic cell maturation and function
. Cellular and Molecular Immunology
.2017
;(14):935-947
|
|
| 51. |
2016
Lee PH,Fu H,Lai T-C,Chiang C-Y,Chan C-C,Lin H-H.
Glycemic control and the risk of tuberculosis: a cohort study
. PLOS Med
.2016
;(13):1-15
|
|
| 52. |
2016
Chiang C-Y,Van Deun A,Rieder HL.
Gatifloxacin for short, effective treatment of multidrug-resistant tuberculosiss
. Int J Tuberc Lung Dis
.2016
;(20):1143-1147
|
|
| 53. |
2016
Bai K-J,Lee J-J,Chien S-T,Suk C-W,Chiang C-Y.
The influence of smoking on pulmonary tuberculosis in diabetic and non-diabetic patients
. PLoS ONE
.2016
;(11):1-12
|
|
| 54. |
2016
Fox GJ,Mitnick CD,Benedetti A,Chan ED,Becerra M,Chiang C-Y, Keshavjee S, Koh W-J, Shiraishi Y, Viiklepp P, Yim J-J, Pasvol G, Robert J, Shim YT, Shi.
Surgery as an adjunctive treatment for multi-drug resistant tuberculosis: an individual patient data meta-analysis
. Clin Infect Dis
.2016
;(62):887-895
|
|
| 55. |
2016
Lo H-Y,Yang S-L,Lin H-H,Bai K-J,Lee J-J,Lee T-I, Chiang C-Y.
Does enhanced diabetic management reduce the risk and improve the outcome of tuberculosis?
. Int J Tuberc Lung Dis
.2016
;(20):376-382
|
|
| 56. |
2016
Lai T-C,Chiang C-Y,Wu C-F,Yang S-L,Liu D-P,Chan C-C, Lin H-H.
Ambient air pollution and risk of tuberculosis: a cohort study
. Occup Environ Med
.2016
;(73):56-61
|
|
| 57. |
2015
Chiang C-Y,Ait-Khaled N,Bissell K,Enarson DA.
Management of asthma in resource limited settings: role of low cost corticosteroid/ beta-agonist combination inhaler
. Int J Tuberc Lung Dis
.2015
;(19):129-136
|
|
| 58. |
2015
Yew WW,Chiang C-Y,Lumb R,Islam T.
Are pulmonary non-tuberculous mycobacteria of concern in the Western Pacific Region?
. Int J Tuberc Lung Dis
.2015
;(19):499-500
|
|
| 59. |
2015
Agodokpessi G,Aït-Khaled N,Gninafon M,Tawo L,Bekou W,Perrin C, Bissell K, Billo N, Enarson DA, Chiang C-Y.
Assessment of a revolving drug fund for essential asthma medicines in Benin
. Journal of Pharmaceutical Policy and Practice
.2015
;(8):1-8
|
|
| 60. |
2015
Chiang C-Y,Bai K-J,Lin H-H,Chien S-T,Lee J-J,Enarson DA, Lee T-I, Yu M-C.
The influence of diabetes, glycemic control, and diabetes-related comorbidities on pulmonary tuberculosis
. PLoS ONE
.2015
;(10):1-15
|
|
| 61. |
2015
Lin Y,Enarson DA,Chiang C-Y,Rusen ID.
Patient delay in the diagnosis and treatment of tuberculosis in China: findings of case detection projects
. Public Health Action
.2015
;(5):65-69
|
|
| 62. |
2015
Islam T,Marais BJ,Nhung NV,Chiang C-Y,Yew WW,Yoshiyama T, Mira NR.
Western Pacific Regional Green Light Committee: progress and way forward
. Int J Infect Dis
.2015
;(32):161-165
|
|
| 63. |
2015
Chiang C-Y,Yu M-C,Yang S-L,Yen M-Y,Bai K-J.
Surveillance of tuberculosis in Taipei: the influence of nontuberculous mycobacteria
. PLoS One
.2015
;(10):1-10
|
|
| 64. |
2015
Chen C-C,Chiang C-Y,PanS-C,Wang J-Y,Lin H-H.
Health system delay among patients with tuberculosis in Taiwan: 2003–2010.
. BMC Infectious Diseases
.2015
;(15):1-9
|
|
| 65. |
2015
Lin Y,Wang L,Qiu L,Huang Q,Shu Q,Lin H, Meng X, Zeng X, Xiao L, Bam TS, Chiang C-Y.
A smoking cessation intervention among tuberculosis patients in rural China
. Public Health Action
.2015
;(5):183-187
|
|
| 66. |
2015
Bam TS,Aditama TY,Chiang C-Y,Rubeah R,Suhaemi A.
Smoking cessation and smokefree environments for tuberculosis patients in Indonesia- a cohort study.
. BMC Public Health
.2015
;(15):1-8
|
|
| 67. |
2014
Lumbani Makwakwa,Mei-ling Sheu,Chen-Yuan Chiang,Shoei-Loong Lin,Peter W Chang.
Patient and health system delays in the diagnosis and treatment of new and retreatment pulmonary tuberculosis cases in Malawi
. BMC Infectious Diseases
.2014
;(14):1-9
|
|
| 68. |
2014
Wen-Yueh Hung,Ming-Chih Yu,Yi-Chun Chiang,Jer-Hwa Chang,Chen-Yuan Chiang,Chih-Cheng Chang, Hsiao-Chi Chuang, Kuan-Jen Bai.
Serum Concentration of Cycloserine and Outcome of Multidrug-Resistant Tuberculosis in Northern Taiwan
. The International Journal of Tuberculosis and Lung Disease
.2014
;(18):601-606
|
|
| 69. |
2014
Lin H-H,Suk C-W,Lo H-L,Huang R-Y,Enarson D A,Chiang C-Y.
Indoor air pollution from solid fuel and tuberculosis: a systematic review and meta-analysis
. The International Journal of Tuberculosis and Lung Disease
.2014
;(18):613-621
|
|
| 70. |
2014
Chiang C-Y,Lee J-J,Chien S-T,Enarson DA,Chang Y-C,Chen Y-T, Hu T-Y, Lin C-B, Suk C-W, Tao J-M, Bai K-J.
Glycemic control and radiographic manifestations of tuberculosis in diabetic patients
. PLoS One
.2014
;(9):1-9
|
|
| 71. |
2013
Chiang CY,Van Deun A.
Rapid diagnosis of rifampicin resistance – who needs confirmation?
. Int J Tuberc Lung Dis
.2013
;(17):2-2
|
|
| 72. |
2013
Wu MH,Chiang CY,Deng YM,Wang TF,Yu CY,Jou R.
Proficiency of Drug Susceptibility Testing for Mycobacterium tuberculosis in Taiwan, 2007-2011
. Int J Tuberc Lung Dis
.2013
;(17):113-119
|
|
| 73. |
2013
Hsu AH,Lee JJ,Chiang CY,Li YH,Chen LK,Lin CB.
Diabetes is associated with drug-resistant tuberculosis in Eastern Taiwan
. Int J Tuberc Lung Dis
.2013
;(17):354-356
|
|
| 74. |
2013
Chiang CY,Van Deun A,Enarson DA.
Bad drug-resistant tuberculosis programme is worse than no programme: time for a change
. Int J Tuberc Lung Dis 2013
.2013
;(17):714-718
|
|
| 75. |
2013
Chiang CY,Van Weezenbeek C,Mori T,Enarson DA.
Challenges to the global control of tuberculosis
. Respirology
.2013
;(18):596-604
|
|
| 76. |
2012
Chen YT,Lee JJ,Chiang CY,Yang GG,Tsai YC,Lee YS, Lin CB.
Effective interventions and decline of anti-tuberculosis drug resistance in Eastern Taiwan, 2004-2008.
. PLoS ONE
.2012
;(7):1-6
|
|
| 77. |
2012
Chiang CY,Bissell K,Perrin C.
Are national asthma programmes needed in resource-limited settings?
. Int J Tuberc Lung Dis
.2012
;(16):572-572
|
|
| 78. |
2012
Kan X,Chiang CY,Enarson DA,RAo H,Chen Q,Aït-Khaled N.
Asthma as a hidden disease in rural China: opportunities and challenges of standard case management
. PHA
.2012
;(2):87-91
|
|
| 79. |
2012
Chiang CY,Yu MC,Shih HC,Yen MY,Hsu YL,Yang SL.
Improved consistency in dosing anti-tuberculosis drugs in Taipei, Taiwan.
. PLoS ONE
.2012
;(7):1-7
|
|
| 80. |
2012
Ahuja SD,Ashkin D,Avendano M,Banerjee R,Bauer M,Bayona JN, Becerra MC,…Chiang CY.
Multidrug-resistant tuberculosis treatment regimens and patient outcomes: an Individual Patient Data (IPD) Meta-Analysis of 9153 patients
. PLoS Med
.2012
;(9):1-16
|
|
| 81. |
2012
Kan XH,Zhang LX,Yang JA,Zhang J,Chiang CY.
Mobilizing elementary and secondary school students for tuberculosis case finding in Anhui, China
. PHA
.2012
;(2):152-156
|
|
| 82. |
2011
Lo H-Y,Yang S-L,Chou P,Chuang J-H,Chiang C-Y.
Completeness and timeliness of tuberculosis notification in Taiwan
. BMC Public Health
.2011
;(11):1-9
|
|
| 83. |
2011
Chiang C-Y,Chee CBE.
The year in review, Part II. What new knowledge about tuberculosis did we gain through the IJTLD?
. Int J Tuberc Lung Dis
.2011
;(15):1598-1607
|
|
| 84. |
2011
Kan X,Chiang C-Y,Enarson DA,Chen W,Yang J,Chen G.
Indoor solid fuel use and tuberculosis in China: a matched case-control study
. BMC Public Health
.2011
;(11):1-7
|
|
| 85. |
2011
Gninafon M,Ade G,Aït-Khaled N,Enarson DA,Chiang C-Y.
Exposure to combustion of solid fuel and tuberculosis: a matched case-control study
. Eur Respir J
.2011
;(38):132-138
|
|
| 86. |
2011
Chiang C-Y,Bai K-J,Enarson DA,Suo J,Luh K-T.
In reply to `Prescriptions for tuberculosis treatment: get it right the first time'
. Int J Tuberc Lung Dis
.2011
;(15):567-568
|
|
| 87. |
2011
Trebucq A,Enarson D A,Chiang C-Y,Van Deun A,Harries A D,Boillot F.
Xpert ® MTB/RIF for national tuberculosis programmes in low-income countries: when, where and how?
. Int J Tuberc Lung Dis
.2011
;(15):1567-1571
|
|
| 88. |
2011
Chiang C-Y,Van Deun A,Trébucq A,Heldal E,Caminero JA,Aït-Khaled N.
Treatment of multidrug-resistant tuberculosis: definition of the outcome “failure”
. Int J Tuberc Lung Dis
.2011
;(15):4-5
|
|
| 89. |
2011
Hinderaker SG,Rusen ID,Chiang C-Y,Lin Y,Heldal E,Enarson DA.
The FIDELIS initiative: Innovative strategies for increased case finding.
. Int J Tuberc Lung Dis
.2011
;(15):71-76
|
|
| 90. |
2010
Huang H-Y,Tsai Y-S,Lee J-J,Chiang M-C,Chiang C-Y,Lin N-T.
Mixed Infection with Beijing and Non-Beijing Strains and Drug Resistance Pattern of Mycobacterium tuberculosis.
. J Clin Microbiol
.2010
;(48):4474-4480
|
|
| 91. |
2010
Hsu A-H,Lin C-B,Lee Y-S,Chiang C-Y,Chen L-K,Lee J-J.
Molecular Epidemiology of Multidrug-Resistant Mycobacterium tuberculosis in Eastern Taiwan
. Int J Tuberc Lung Dis
.2010
;(14):924-926
|
|
| 92. |
2010
Chiang C-Y,Schaaf HS.
Management of drug-resistant tuberculosis.
. Int J Tuberc Lung Dis
.2010
;(14):672-682
|
|
| 93. |
2010
Chiang C-Y,Centis R,Migliori GB.
Drug-resistant tuberculosis: Past, present, and future.
. Respirology
.2010
;(15):413-32
|
|
| 94. |
2010
Slama K,Chiang C-Y,Hinderaker SG,Bruce N,Vedal S,Enarson DA.
Indoor solid fuel combustion and tuberculosis: is there an association?
. Int J Tuberc Lung Dis
.2010
;(14):6-14
|
|
| 95. |
2010
Gninafon M,Ade G,Aït-Khaled N,Enarson DA,Chiang C-Y.
Exposure to combustion of solid fuel and tuberculosis: a matched case-control study
. Eur Respir J ERJ Express. Published on October 28, 2010 as doi: 10.1183/09031936.00104610
.2010
|
|
| 96. |
2010
Chiang C-Y,Bai K-J,Lee C-N,Enarson DA,Suo J,Luh K-T.
Inconsistent dosing of anti-tuberculosis drugs in Taipei
. Int J Tuberc Lung Dis
.2010
;(14):878-883
|
|
| 97. |
2009
Chiang C-Y,Lee J-J,Yu M-C,Enarson DA,Lin T-P,Luh K-T.
Tuberculosis outcomes in Taipei: factors associated with treatment interruption for 2 months and death
. Int J Tuberc Lung Dis
.2009
;(13):105-111
|
|
| 98. |
2009
Chiang C-Y,Lee J-J,Yu M-C,Bai K-J,Lin T-P,Luh K-T.
Tuberculosis-related deaths without treatment
. Int J Tuberc Lung Dis
.2009
;(13):1563-1565
|
|
| 99. |
2009
Chiang C-Y,Yew WW.
Multidrug-resistant and extensively drug-resistant tuberculosis
. Int J Tuberc Lung Dis
.2009
;(13):304-311
|
|